| This article has been cited by |
| 1 | A method of inhibiting the ABCB1 protein in the blood-brain barrier in vivo | |
| Ivan V. Chernykh,Alexey V. Shchulkin,Pavel Yu. Mylnikov,Ekaterina E. Kirichenko,Maria V. Gatsanoga,Elena N. Yakusheva |
| Annals of Clinical and Experimental Neurology.2022;16(3)47 |
| [DOI] |
|
| 2 | Effects of triptolide on the pharmacokinetics of cyclophosphamide in rats: A possible role of CytochromeP3A4 inhibition | |
| Xi-feng Zhang,Ju Liu,Feng Ye,Sen-guo Ji,Ni Zhang,Ru-sen Cao,Ling He,Jiang-chuan Wu,Xing-fu Li |
| Chinese Journal of Integrative Medicine.2014;20(7)534 |
| [DOI] |
|
| 3 | EVALUATION OF ABCB1-PROTEIN INHIBITION PROSPECTIVENESS IN HEMATOENCEPHALIC BARRIER AS METHOD FOR INCREASING EFFICIENCY OF PHARMACOTHERAPY IN CEREBRAL ISCHEMIA | |
| I. V. Chernykh,A. V. Shchulkin,M. V. Gatsanoga,E. N. Yakusheva |
| Pharmacy & Pharmacology.2022;10(1)104 |
| [DOI] |
|
| 4 | A Response to the Letter of Iba on Liu et al
., 2012. Effects of Panax notoginseng
Saponins on the Activities of CYP1A2, CYP2C9, CYP2D6 and CYP3A4 in Rats In Vivo. Phytother Res
26: 1113-1118. | |
| Gaofeng Liu |
| Phytotherapy Research.2014;28(1)152 |
| [DOI] |
|
| 5 | Isolated Hemopericardium after Initiation of Rivaroxaban: Implications and Potential Mechanisms | |
| Adwait Mehta,David Burkland,Nilesh Mathuria |
| Clinics and Practice.2019;9(1)1096 |
| [DOI] |
|
